DARKPOOL0.1.0
AFT-MKT Sign in
SOLV
Solventum Corporation
NYQ Equity
88.62
-1.46 (-1.62%)
52w low 62.38 94.16 high
82.6% of range
Open
89.30
High
90.26
Low
88.46
Prev Close
90.08
Volume
728.27K
Avg Vol 3M
1.07M
Market Cap
15.06B
Currency
USD

6 Month Trend

full chart ›
— C-- Chg-- Gap-- Vol-- ×avg-- σ-- SMA20-- SMA50-- SMA200-- RSI-- SPY-- DD-- Bench-- Sig-- Hist-- hover · click to pin · ← → step · drag to zoom · shift-drag to measure
70.0080.0090.00May 26Jun 26Jul 26Aug 26Sep 26Nov 26
—Context
  • Move across the chart.

Company

SectorHealthcare
IndustryMedical Instruments & Supplies
CountryUnited States
Employees20,584
Website ↗

Performance

change over each horizon
1D -1.62%
5D -0.82%
1M +3.88%
3M +3.90%
6M +19.10%
YTD +11.84%
1Y +19.95%
2Y +23.89%
3Y --
5Y --
MAX +27.42%

Technical Rating

990 daily bars
Buy
4 bullish 1 bearish 1 neutral
SignalReading
+ Price vs 50-day average 88.62 vs 87.01
+ Price vs 200-day average 88.62 vs 84.57
+ 50-day vs 200-day 87.01 vs 84.57
+ MACD histogram +0.664
− 3-month rate of change -0.2%
· RSI (14) 54.9 (neutral)

A mechanical summary of past prices only — six indicators, one vote each. It uses no fundamentals, no news and no knowledge of your circumstances, and the signals disagree by design. Not investment advice.

ML Prediction

990 daily bars
HOLD
SignalReading
Predicted next close 88.95
Predicted change +0.37%
Trend UP
Support / Resistance 80.98 / 91.39
Track record 100% of 1 provisional
  • predicted move too small to call

A mechanical fit to past prices, nothing more — no fundamentals, no news, no view of your circumstances. Historically close to a coin flip on direction (see the backtest). Not investment advice.

Valuation

P/E Trailing99.57x
P/E Forward11.75x
Price / Book3.13x
Price / Sales1.85x
EV / EBITDA20.07x
EPS Trailing0.89
Dividend Yield0.00%
Beta0.75

Profitability

Gross Margin53.83%
Operating Margin5.91%
Net Margin1.91%
Return on Equity3.19%
Return on Assets2.14%
Revenue Growth-7.00%
Debt / Equity1.10x
Current Ratio1.03x

Business

Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally. It operates through three segments: Medsurg, Dental Solutions, and Health Information Systems. The Medsurg segment offers solutions, such as negative pressure wound therapy, advanced wound dressings, advanced skin care, synthetic tissue matrices, I.V. site management, sterilization assurance, temperature management, surgical supplies, medical tapes and wraps, stethoscopes, medical electrodes, and medical technologies for original equipment manufacturers. The Dental Solutions segment provides dental and orthodontic products, including brackets, aligners, restorative cements, and bonding agents to span the life of the tooth, and products for preventative dental care, direct and indirect restoration, and orthodontic needs. The Health Information Systems segment offers healthcare systems with software solutions comprising computer-assisted physician documentation, direct-to-bill and coding automation, classification methodologies, speech recognition, and data visualization platforms. The company sells its products and services through direct-to-consumer, distribution, key account management, inside sales, and e-commerce. Solventum Corporation was incorporated in 2023 and is headquartered in Eagan, Minnesota.